• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于骨与软骨修复的基于蛋白质的组织工程

Protein-based tissue engineering in bone and cartilage repair.

作者信息

Wozney John M, Seeherman Howard J

机构信息

Wyeth Research, 87 CambridgePark Drive, Cambridge, Massachusetts 02140, USA.

出版信息

Curr Opin Biotechnol. 2004 Oct;15(5):392-8. doi: 10.1016/j.copbio.2004.08.001.

DOI:10.1016/j.copbio.2004.08.001
PMID:15464367
Abstract

Bioactive proteins signal host or transplanted cells to form the desired tissue type. Matrix systems are utilized to locally deliver the proteins and to maintain effective protein concentrations. For some indications, a matrix is required to define the physical form of the regenerated tissue. Substantial progress has been made in bone tissue engineering in recent years, based on the results of controlled clinical studies using bone morphogenetic proteins. Ongoing research in this area centers on the design of additional delivery matrices to expand the clinical indications, using synthetic delivery systems that mimic biological qualities of the natural materials currently in use. Although a similar rationale exists for the regeneration of articular cartilage with bioactive factors, advancement in this area has not been as substantial.

摘要

生物活性蛋白向宿主细胞或移植细胞发出信号,以形成所需的组织类型。利用基质系统来局部递送这些蛋白并维持有效的蛋白浓度。对于某些适应症,需要一种基质来确定再生组织的物理形态。近年来,基于使用骨形态发生蛋白的对照临床研究结果,骨组织工程取得了重大进展。该领域正在进行的研究集中在设计额外的递送基质以扩大临床适应症,采用模仿目前所用天然材料生物学特性的合成递送系统。尽管利用生物活性因子再生关节软骨也有类似的基本原理,但该领域的进展并不那么显著。

相似文献

1
Protein-based tissue engineering in bone and cartilage repair.用于骨与软骨修复的基于蛋白质的组织工程
Curr Opin Biotechnol. 2004 Oct;15(5):392-8. doi: 10.1016/j.copbio.2004.08.001.
2
Delivery of bone morphogenetic proteins for orthopedic tissue regeneration.用于骨科组织再生的骨形态发生蛋白递送
Cytokine Growth Factor Rev. 2005 Jun;16(3):329-45. doi: 10.1016/j.cytogfr.2005.05.001.
3
Protein- and gene-based tissue engineering in bone repair.基于蛋白质和基因的组织工程在骨修复中的应用
Curr Opin Biotechnol. 2004 Oct;15(5):399-405. doi: 10.1016/j.copbio.2004.07.004.
4
Matrices and scaffolds for delivery of bioactive molecules in bone and cartilage tissue engineering.用于骨和软骨组织工程中生物活性分子递送的基质和支架
Adv Drug Deliv Rev. 2007 May 30;59(4-5):339-59. doi: 10.1016/j.addr.2007.03.016. Epub 2007 Apr 12.
5
Smart biomaterials for tissue engineering of cartilage.用于软骨组织工程的智能生物材料。
Injury. 2008 Apr;39 Suppl 1:S77-87. doi: 10.1016/j.injury.2008.01.036.
6
Repair and regeneration of osteochondral defects in the articular joints.关节软骨下骨缺损的修复与再生
Biomol Eng. 2007 Nov;24(5):489-95. doi: 10.1016/j.bioeng.2007.07.014. Epub 2007 Aug 7.
7
Bone morphogenetic proteins in tissue engineering: the road from laboratory to clinic, part II (BMP delivery).组织工程中的骨形态发生蛋白:从实验室到临床之路,第二部分(骨形态发生蛋白的递送)
J Tissue Eng Regen Med. 2008 Mar-Apr;2(2-3):81-96. doi: 10.1002/term.74.
8
[Tissue engineered bone regeneration of periosteal cells using recombinant human bone morphogenetic protein 2 induce].使用重组人骨形态发生蛋白2诱导骨膜细胞进行组织工程骨再生
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2005 Feb;19(2):100-4.
9
Use of bone morphogenetic protein 2 and diffusion chambers to engineer cartilage tissue for the repair of defects in articular cartilage.使用骨形态发生蛋白2和扩散室构建软骨组织以修复关节软骨缺损。
Arthritis Rheum. 2005 Jan;52(1):155-63. doi: 10.1002/art.20713.
10
Bone tissue engineering by gene delivery.通过基因递送进行骨组织工程
Adv Drug Deliv Rev. 2006 Jul 7;58(4):555-76. doi: 10.1016/j.addr.2006.03.008. Epub 2006 Jun 21.

引用本文的文献

1
Injectable pH-responsive adhesive hydrogels for bone tissue engineering inspired by the underwater attachment strategy of marine mussels.受海洋贻贝水下附着策略启发的用于骨组织工程的可注射 pH 响应性粘附水凝胶。
Biomater Adv. 2022 Feb;133:112606. doi: 10.1016/j.msec.2021.112606. Epub 2021 Dec 13.
2
Preparation and characterization of a novel drug-loaded Bi-layer scaffold for cartilage regeneration.一种用于软骨再生的新型载药双层支架的制备与表征
RSC Adv. 2022 Mar 25;12(16):9524-9533. doi: 10.1039/d2ra00311b.
3
In vivo potency assay for the screening of bioactive molecules on cartilage formation.
体内效力测定法在软骨形成中筛选生物活性分子的应用。
Lab Anim (NY). 2022 Apr;51(4):103-120. doi: 10.1038/s41684-022-00943-y. Epub 2022 Mar 31.
4
Characterization of Properties, In Vitro and In Vivo Evaluation of Calcium Phosphate/Amino Acid Cements for Treatment of Osteochondral Defects.用于治疗骨软骨缺损的磷酸钙/氨基酸骨水泥的性能表征、体外和体内评价
Materials (Basel). 2021 Jan 17;14(2):436. doi: 10.3390/ma14020436.
5
Facile fabrication of the zoledronate-incorporated coating on magnesium alloy for orthopaedic implants.用于骨科植入物的镁合金上唑来膦酸盐结合涂层的简便制备。
J Orthop Translat. 2019 Oct 18;22:2-6. doi: 10.1016/j.jot.2019.09.007. eCollection 2020 May.
6
The synergetic effect of bioactive molecule-loaded electrospun core-shell fibres for reconstruction of critical-sized calvarial bone defect-The effect of synergetic release on bone Formation.载生物活性分子的电纺核壳纤维在重建临界尺寸颅骨骨缺损中的协同效应-协同释放对成骨的影响。
Cell Prolif. 2020 Apr;53(4):e12796. doi: 10.1111/cpr.12796. Epub 2020 Mar 22.
7
Phosphate functionalization and enzymatic calcium mineralization synergistically enhance oligo[poly(ethylene glycol) fumarate] hydrogel osteoconductivity for bone tissue engineering.磷酸盐功能化和酶诱导钙矿化协同增强聚[聚(乙二醇)富马酸]水凝胶的骨传导性用于骨组织工程。
J Biomed Mater Res A. 2020 Mar;108(3):515-527. doi: 10.1002/jbm.a.36832. Epub 2019 Nov 26.
8
Analysis of Osteoblast Culture on Scaffolds for Future Bone Regeneration Purposes in Dentistry.用于牙科未来骨再生目的的支架上成骨细胞培养分析
Adv Pharmacol Sci. 2019 Feb 6;2019:5420752. doi: 10.1155/2019/5420752. eCollection 2019.
9
Harnessing supramolecular peptide nanotechnology in biomedical applications.在生物医学应用中利用超分子肽纳米技术。
Int J Nanomedicine. 2017 Feb 9;12:1171-1182. doi: 10.2147/IJN.S126154. eCollection 2017.
10
Engineered cell-free scaffold with two-stage delivery of miRNA-26a for bone repair.用于骨修复的具有miRNA-26a两阶段递送功能的工程化无细胞支架
Ann Transl Med. 2016 May;4(10):204. doi: 10.21037/atm.2016.05.28.